ArticleAging2021

CRISPR/Cas9-mediated CysLT1R deletion reverses synaptic failure, amyloidosis and cognitive impairment in APP/PS1 mice.

Fang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.